{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:09:34Z","timestamp":1790863774486,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Malaria in pregnancy is a major public health issue, particularly among vulnerable populations in malaria-endemic sub-Saharan African countries. To mitigate its risks, WHO recommends sulphadoxine-pyrimethamine (SP) for chemoprevention and artemisinin-based combination therapy (ACT) to treat uncomplicated\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      malaria. These interventions have helped to alleviate the risk associated with malaria in pregnancy; however, in the context of the emergence of SP- and ACT-resistant\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      , maintained efficacy is under threat. Molecular surveillance is a reliable tool to monitor the emergence of resistance where molecular markers are known. Thus, the objective of the study was to use a multiplexed amplicon Oxford Nanopore sequencing approach to assess the molecular markers for antimalarial resistance among pregnant women in Nigeria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Dried blood spots (DBS) were collected from pregnant women who received IPTp-SP at the enrollment and follow-up visits.\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      genomic DNA was extracted by the Chelex\n                      <jats:sup>\u00ae<\/jats:sup>\n                      method and\n                      <jats:italic>Pf<\/jats:italic>\n                      18S qPCR was used to detect parasite DNA in each sample. With nested PCR assays, fragments of\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      ,\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      ,\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      ,\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      ,\n                      <jats:italic>Pfk13<\/jats:italic>\n                      and\n                      <jats:italic>Pfama1<\/jats:italic>\n                      genes were amplified and multiplexed amplicon-based sequencing was conducted on the minION Oxford Nanopore Technology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      In total, 251 pregnant women were enrolled in the study and 457 DBS samples were collected.\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      genomic DNA was detected in 12% (56\/457) of the samples, 31 at baseline and the remaining during the follow-up visits.\n                      <jats:italic>Pfama1<\/jats:italic>\n                      ,\n                      <jats:italic>pfk13<\/jats:italic>\n                      ,\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      ,\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      ,\n                      <jats:italic>Pfmdr1 and Pfcrt<\/jats:italic>\n                      were successfully sequenced in a single run. Notably, k13 artemisinin resistance mutations were absent, the frequencies of\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      and\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      SP resistance haplotypes,\n                      <jats:bold>IRN<\/jats:bold>\n                      for pyrimethamine resistance and I\n                      <jats:bold>SG<\/jats:bold>\n                      KA\/IA\n                      <jats:bold>G<\/jats:bold>\n                      KA associated with sulphadoxine resistance were 82% (36\/44) and 64% (27\/42), respectively, and the\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      CV\n                      <jats:bold>IET<\/jats:bold>\n                      resistant haplotype was at approximately 22% (7\/32).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and recommendations<\/jats:title>\n                    <jats:p>\n                      Here a multiplexed amplicon-based ONT assay established that triple mutant\n                      <jats:italic>Pfdfhr<\/jats:italic>\n                      -IRN, double mutant\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      -SG haplotypes and the chloroquine sensitive strain were prevalent among pregnant women in Nigeria.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2024.1470156","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:51:49Z","timestamp":1728989509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["ONT sequencing identifies a high prevalence of crt sensitive, triple mutant dhfr and single mutant dhps parasites within an ANC population in Nigeria"],"prefix":"10.3389","volume":"15","author":[{"given":"Adebanjo Jonathan","family":"Adegbola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Ndwiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Osoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluseye Oladotun","family":"Bolaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette Isabella","family":"Ochola-Oyier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/diseases9010006","article-title":"Polymorphism analysis of pfmdr1 and pfcrt from Plasmodium falciparum isolates in northwestern Nigeria revealed the major markers associated with antimalarial resistance","volume":"9","author":"Adam","year":"2021","journal-title":"Diseases"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-023-04487-5","article-title":"A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria","volume":"22","author":"Adegbola","year":"2023","journal-title":"Malar. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0264548","DOI":"10.1371\/journal.pone.0264548","article-title":"Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria","volume":"17","author":"Ajogbasile","year":"2022","journal-title":"PLOS ONE"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3201\/eid2008.131897","article-title":"Independent origin of Plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia","volume":"20","author":"Alifrangis","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12936-021-03883-z","article-title":"The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review","volume":"20","author":"Bakken","year":"2021","journal-title":"Malar. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"621382","DOI":"10.3389\/fimmu.2021.621382","article-title":"Poor birth outcomes in malaria in pregnancy: recent insights into mechanisms and prevention approaches","volume":"12","author":"Chua","year":"","journal-title":"Front. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"777343","DOI":"10.3389\/fmicb.2021.777343","article-title":"Malaria in pregnancy: from placental infection to its abnormal development and damage","volume":"12","author":"Chua","year":"","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(15)00310-4","article-title":"Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial","volume":"386","author":"Desai","year":"2015","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","article-title":"Epidemiology and burden of malaria in pregnancy","volume":"7","author":"Desai","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12936-019-2986-5","article-title":"A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali","volume":"18","author":"Diakit\u00e9","year":"2019","journal-title":"Malar. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12936-023-04615-1","article-title":"Assessment of genetic polymorphisms associated with malaria antifolate resistance among the population of Libreville, Gabon","volume":"22","author":"Dinzouna-Boutamba","year":"2023","journal-title":"Malar. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0064621","DOI":"10.1128\/JCM.00646-21","article-title":"Nanopore sequencing for Mycobacterium tuberculosis: a critical review of the literature, new developments, and future opportunities","volume":"60","author":"Dippenaar","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1258952","DOI":"10.3389\/frph.2023.1258952","article-title":"Prevalence of asymptomatic malaria and associated factors among pregnant women in Ethiopia: systematic review and meta-analysis","volume":"5","author":"Duguma","year":"2023","journal-title":"Front. Reproductive Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/pathogens12060844","article-title":"Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnancy: low coverage and high prevalence of plasmodium falciparum dhfr-dhps quintuple mutants as major challenges in douala, an urban setting in Cameroon","volume":"12","author":"Eboumbou Moukoko","year":"2023","journal-title":"Pathogens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"104503","DOI":"10.1016\/j.meegid.2020.104503","article-title":"Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria","volume":"85","author":"Fagbemi","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12936-020-3152-9","article-title":"Asymptomatic malaria infection among pregnant women attending antenatal care in malaria endemic areas of North-Shoa, Ethiopia: a cross-sectional study","volume":"19","author":"Feleke","year":"2020","journal-title":"Malar. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/s1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12936-020-03263-z","article-title":"Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya","volume":"19","author":"Gikunju","year":"2020","journal-title":"Malar. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/s41564-023-01516-6","article-title":"Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana","volume":"8","author":"Girgis","year":"2023","journal-title":"Nat. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.eclinm.2021.101160","article-title":"Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials","volume":"41","author":"Gutman","year":"2021","journal-title":"eClinicalMedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4269\/ajtmh.2006.75.155","article-title":"Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria\u2013infected children in Nigeria","volume":"75","author":"Happi","year":"2006","journal-title":"Am. J. Trop. Med. Hyg. Am J Trop Med Hyg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12936-022-04304-5","article-title":"High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia","volume":"21","author":"Hassen","year":"2022","journal-title":"Malar. J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gkx1201","article-title":"SeekDeep: single-base resolution de novo clustering for amplicon deep sequencing","volume":"46","author":"Hathaway","year":"2018","journal-title":"Nucleic acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3201\/eid2202.151796","article-title":"Nanopore sequencing as a rapidly deployable Ebola outbreak tool","volume":"22","author":"Hoenen","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.meegid.2007.03.005","article-title":"Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa","volume":"7","author":"Holmgren","year":"2007","journal-title":"Infect. Genet. Evol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12936-019-2947-z","article-title":"Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria","volume":"18","author":"Idowu","year":"2019","journal-title":"Malar. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1475-2875-11-134","article-title":"Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya","volume":"11","author":"Iriemenam","year":"2012","journal-title":"Malar. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","article-title":"Monthly sulfadoxine\u2013pyrimethamine versus dihydroartemisinin\u2013piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial","volume":"393","author":"Kajubi","year":"2019","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(22)02535-1","article-title":"Effect of monthly intermittent preventive treatment with dihydroartemisinin\u2013piperaquine with and without azithromycin versus monthly sulfadoxine\u2013pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial","volume":"401","author":"Madanitsa","year":"2023","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41598-017-02724-x","article-title":"High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology","volume":"7","author":"Nag","year":"2017","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","article-title":"Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria","volume":"29","author":"Naidoo","year":"2013","journal-title":"Trends Parasitol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"102657","DOI":"10.1016\/j.parint.2022.102657","article-title":"Anti-folate quintuple mutations in Plasmodium falciparum asymptomatic infections in Yaound\u00e9, Cameroon","volume":"92","author":"Nana","year":"2023","journal-title":"Parasitol. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","article-title":"Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V","volume":"6","author":"Oguike","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-023-04506-5","article-title":"Accuracy of diagnosis among clinical malaria patients: comparing microscopy, RDT and a highly sensitive quantitative PCR looking at the implications for submicroscopic infections","volume":"22","author":"Opoku Afriyie","year":"2023","journal-title":"Malar. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0194521","DOI":"10.1128\/aac.01945-21","article-title":"Targeted amplicon deep sequencing for monitoring antimalarial resistance markers in western Kenya","volume":"66","author":"Osoti","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4269\/ajtmh.1996.55.467","article-title":"Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance","volume":"55","author":"Plowe","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/genetics\/158.4.1505","article-title":"Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene","volume":"158","author":"Polley","year":"2001","journal-title":"Genetics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40249-020-00712-4","article-title":"High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria","volume":"9","author":"Quan","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1016\/S2214-109X(20)30119-4","article-title":"Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis","volume":"8","author":"Roh","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"Roper","year":"2004","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","article-title":"High prevalence of plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine","volume":"225","author":"Straimer","year":"2022","journal-title":"J. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-023-04645-9","article-title":"Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso","volume":"22","author":"Tarama","year":"2023","journal-title":"Malar. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0231477","DOI":"10.1371\/journal.pone.0231477","article-title":"Prevalence of asymptomatic Plasmodium species infection and associated factors among pregnant women attending antenatal care at Fendeka town health facilities, Jawi District, North west Ethiopia: a cross-sectional study","volume":"15","author":"Tilahun","year":"2020","journal-title":"PLOS ONE"},{"key":"B46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1475-2875-8-224","article-title":"Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens","volume":"8","author":"Tiono","year":"2009","journal-title":"Malar. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12864-022-08541-5","article-title":"Comparison of SARS-CoV-2 sequencing using the ONT GridION and the illumina MiSeq","volume":"23","author":"Tshiabuila","year":"2022","journal-title":"BMC Genomics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/infdis\/jiac144","article-title":"Amplicon sequencing as a potential surveillance tool for complexity of infection and drug resistance markers in Plasmodium falciparum asymptomatic infections","volume":"226","author":"Wamae","year":"2022","journal-title":"J. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e01067-19","DOI":"10.1128\/AAC.01067-19","article-title":"No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites","volume":"63","author":"Wamae","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","volume-title":"Guidelines for malaria: WHO Guidelines for malaria","year":""},{"key":"B52","volume-title":"Report on malaria in Nigeria 2022","year":""},{"key":"B53","volume-title":"World malaria report 2023","year":""}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1470156\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:01:31Z","timestamp":1729141291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1470156\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":53,"alternative-id":["10.3389\/fgene.2024.1470156"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1470156","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"article-number":"1470156"}}